| scholarly article | Q13442814 |
| P2093 | author name string | P. A. Ward | |
| E. Schmid | |||
| M. Miyasaka | |||
| T. E. Hugli | |||
| H. P. Friedl | |||
| K. J. Johnson | |||
| G. O. Till | |||
| R. L. Warner | |||
| M. S. Mulligan | |||
| R. B. Brauer | |||
| B. Beck-Schimmer | |||
| P2860 | cites work | GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies | Q24621927 |
| C5a-induced expression of P-selectin in endothelial cells | Q24633672 | ||
| Role of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in acute lung injury in rats | Q28575979 | ||
| Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency | Q28581576 | ||
| Acute immunologic pulmonary alveolitis | Q34464924 | ||
| Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140) | Q35607537 | ||
| Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation | Q35763398 | ||
| Endotoxin-induced shock in the rat. A role for C5a | Q35816751 | ||
| Mediators of lung injury in mice following systemic activation of complement | Q35835559 | ||
| Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat. | Q35856223 | ||
| A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation | Q35863960 | ||
| Role of complement in inflammation and bacterial killing | Q36049481 | ||
| Complement fragments, alveolar macrophages, and alveolitis | Q36093105 | ||
| The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats | Q36270882 | ||
| The role of complement in inflammation and phagocytosis | Q36845189 | ||
| Role of complement activation in a model of adult respiratory distress syndrome | Q37029141 | ||
| Release of histamine from rat mast cells by the complement peptides C3a and C5a. | Q39327002 | ||
| Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites | Q40681055 | ||
| Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates | Q40682681 | ||
| Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes | Q40690752 | ||
| Acute inflammatory pulmonary reactions induced by chemotactic factors | Q41719277 | ||
| Tumor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1 | Q42050212 | ||
| Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts | Q46310947 | ||
| Complement levels in septic primates treated with anti-C5a antibodies | Q46475101 | ||
| Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface | Q47172907 | ||
| Complement activation during cardiopulmonary bypass. | Q51878205 | ||
| Platelet-serotonin release by C3a and C5a: two independent pathways of activation. | Q53948626 | ||
| The pulmonary response of C5 sufficient and deficient mice to immune complexes. | Q54313632 | ||
| Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury | Q67841876 | ||
| Monocyte chemoattractant protein 1 in a rat model of pulmonary granulomatosis | Q68055867 | ||
| Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions | Q68456479 | ||
| Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation | Q68819023 | ||
| Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis | Q68856319 | ||
| Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation | Q70168776 | ||
| Production of acute pulmonary injury by leukocytes and activated complement | Q71225282 | ||
| Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1 | Q71704986 | ||
| Complement-induced vascular leukostasis. Its role in tissue injury | Q71851171 | ||
| Role of beta 1, beta 2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes | Q72072937 | ||
| Hereditary C6 deficiency in a strain of PVG/c rats | Q72179312 | ||
| Role of leukocyte adhesion molecules in complement-induced lung injury | Q72212765 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 503–512 | |
| P577 | publication date | 1996-07-15 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Requirement and role of C5a in acute lung inflammatory injury in rats | |
| P478 | volume | 98 |
| Q34575286 | ARDS. The future. |
| Q35747453 | Activator protein-1 activation in acute lung injury |
| Q37365949 | Acute lung injury induced by lipopolysaccharide is independent of complement activation |
| Q34353016 | Anaphylatoxins and infectious and non-infectious inflammatory diseases |
| Q36102850 | Anti-KC autoantibody:KC complexes cause severe lung inflammation in mice via IgG receptors |
| Q24681571 | Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor |
| Q37415851 | Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells |
| Q55399408 | Beneficial effects of Houttuynia cordata polysaccharides on "two-hit" acute lung injury and endotoxic fever in rats associated with anti-complementary activities. |
| Q27677832 | Bifunctional Lipocalin Ameliorates Murine Immune Complex-induced Acute Lung Injury |
| Q81009319 | Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats |
| Q73605659 | C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion |
| Q39693535 | C5L2, the Second C5a Anaphylatoxin Receptor, Suppresses LPS-Induced Acute Lung Injury |
| Q37170021 | C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome |
| Q58524108 | C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury☆,☆☆ |
| Q44704923 | CD40 plays a crucial role in lipopolysaccharide-induced acute lung injury. |
| Q34257488 | CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction? |
| Q33852682 | Complement activation following oxidative stress |
| Q35745581 | Complement activation promotes muscle inflammation during modified muscle use. |
| Q41707664 | Complement factors and their receptors |
| Q47899124 | Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma |
| Q36572985 | Complement in lung disease |
| Q34572165 | Complement levels and activity in the normal and LPS-injured lung |
| Q33463280 | Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways |
| Q95816944 | Cytokine-induced neutrophil chemoattractant in a rat model of lipopolysaccharide-induced acute lung injury |
| Q38322785 | Derivation of RNA aptamer inhibitors of human complement C5. |
| Q35753557 | Differing patterns of P-selectin expression in lung injury |
| Q48013552 | Effect of Tityus serrulatus scorpion venom and its major toxin, TsTX-I, on the complement system in vivo |
| Q35028480 | Effects of a new C5a receptor antagonist on C5a- and endotoxin-induced neutropenia in the rat. |
| Q39514766 | Endotoxin-induced lung inflammation is independent of the complement membrane attack complex |
| Q40963571 | Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB. |
| Q36608048 | Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin |
| Q34650129 | Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation |
| Q24669712 | Function, structure and therapeutic potential of complement C5a receptors |
| Q35747767 | Generation of C5a by phagocytic cells |
| Q58523865 | Generation of C5a in the absence of C3: a new complement activation pathway |
| Q44316816 | Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition |
| Q43111270 | Inadequate cytoplasmatic calcium signals in alveolar macrophages after cardiac surgery |
| Q35555743 | Infliximab treatment reduces complement activation in patients with rheumatoid arthritis |
| Q51653367 | Inhibition of Complement Activation Decreases Airway Inflammation and Hyperresponsiveness |
| Q37206724 | Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis |
| Q36625494 | Inhibition of neutrophil exocytosis ameliorates acute lung injury in rats |
| Q38117742 | Insights into thrombin activatable fibrinolysis inhibitor function and regulation. |
| Q34070667 | Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation |
| Q33746056 | Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass |
| Q36195432 | Lung transplantation: opportunities for research and clinical advancement |
| Q41686936 | Mechanisms and regulation of polymorphonuclear leukocyte and eosinophil adherence to human airway epithelial cells. |
| Q35786898 | Mechanisms of enhanced lung injury during sepsis |
| Q34749367 | Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model |
| Q77587543 | Mediators of microvascular injury in dermal burn wounds |
| Q35783409 | MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I. |
| Q46946037 | Minor role of the C3a receptor in systemic anaphylaxis in the guinea pig. |
| Q35834611 | Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. |
| Q26825724 | Molecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"? |
| Q35765528 | NF-kappaB activation during IgG immune complex-induced lung injury: requirements for TNF-alpha and IL-1beta but not complement |
| Q33642557 | Neutrophil and endothelial cell interactions in sepsis. The role of adhesion molecules |
| Q28583530 | Neutrophil chemotactic activity and C5a following systemic activation of complement in rats |
| Q34619641 | Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. |
| Q26751027 | New Insights into Molecular Mechanisms of Immune Complex-Induced Injury in Lung |
| Q35103579 | Novel chemokine responsiveness and mobilization of neutrophils during sepsis |
| Q33852667 | On the role of complement and Fc gamma-receptors in the Arthus reaction |
| Q42048652 | Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor |
| Q38961575 | Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury |
| Q44260666 | Protective effects of C5a blockade in sepsis |
| Q26852032 | Protein-based therapies for acute lung injury: targeting neutrophil extracellular traps |
| Q41432492 | Recruitment of inflammatory cells into lung: roles of cytokines, adhesion molecules, and complement |
| Q34355402 | Regulation of experimental lung inflammation |
| Q35843243 | Regulatory effects of iNOS on acute lung inflammatory responses in mice |
| Q73961038 | Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9 |
| Q36022727 | Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis |
| Q95809683 | Role of chemotactic factors in neutrophil activation after thermal injury in rats |
| Q41707676 | Role of the complement system in pulmonary disorders. |
| Q42804051 | Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury |
| Q27027282 | Sepsis and ARDS: The Dark Side of Histones |
| Q35786952 | Synergistic enhancement of chemokine generation and lung injury by C5a or the membrane attack complex of complement |
| Q35882816 | Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock |
| Q40863588 | The C5a receptor is expressed by human renal proximal tubular epithelial cells |
| Q35153653 | The complement system as a therapeutic target in autoimmunity |
| Q74492380 | The immunologic response to injury |
| Q35963146 | The role of complement in inflammatory diseases from behind the scenes into the spotlight |
| Q37275159 | The role of the complement system in acute kidney injury |
| Q36401591 | Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury |
| Q37086054 | Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response |
| Q36435638 | Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo |
| Q36923847 | Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system |
Search more.